Showing results (2891-2900 of 3,717) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|July 25, 2015
Evaluation of cytotoxic activity of titanocene difluorides and determination of their mechanism of action in ovarian cancer cellsLucie Koubkova, Rostislav Vyzula, Jindrich Karban, et al.
Investigational New Drugs|January 1, 1985
A phase I trial of ametantrone acetate (NSC-287513)R A Gams, F Ostroy, J F Bender, et al.
Investigational New Drugs|November 1, 1989
Assessment of N-methylformamide (NMF) administered orally on a three times weekly schedule: a phase I studyE K Rowinsky, L B Grochow, A Hantel, et al.
Investigational New Drugs|May 9, 2015
Co-administration of antigen with chemokine MCP-3 or MDC/CCL22 enhances DNA vaccine potencyXinmei Xie, Lin Wang, Wenliang Yang, et al.
Investigational New Drugs|May 6, 2020
CPBMF65, a synthetic human uridine phosphorylase-1 inhibitor, reduces HepG2 cell proliferation through cell cycle arrest and senescenceElisa Feller Gonçalves da Silva, Kelly Goulart Lima, Gabriele Catyana Krause, et al.
Investigational New Drugs|May 8, 2020
Phase I study of DFP-11207, a novel oral fluoropyrimidine with reasonable AUC and low Cmax and improved tolerability, in patients with solid tumorsJaffer A Ajani, Milind Javle, Cathy Eng, et al.
Investigational New Drugs|May 5, 2020
Apatinib, a novel VEGFR-2 tyrosine kinase inhibitor, for relapsed and refractory nasopharyngeal carcinoma: data from an open-label, single-arm, exploratory studyLing Li, Fei Kong, Lei Zhang, et al.
Investigational New Drugs|January 1, 1997
Matrix metalloproteinase inhibitors: present achievements and future prospectsL J Denis, J Verweij
Investigational New Drugs|January 1, 1997
Cardiotoxicity of a new anthracycline derivative (SM-5887) following intravenous administration to rabbits: comparative study with doxorubicinT Suzuki, S Minamide, T Iwasaki, et al.
Investigational New Drugs|January 1, 1997
A phase II Southwest Oncology Group study of cisplatin and continuous infusion vinblastine in the treatment of advanced soft tissue sarcomaM L Keohan, M R Grever, S P Balcerzak, et al.
Pageof 372